Extrawell Pharmaceutical Holdings Limited
HKEX:0858.HK
0.05 (HKD) • At close November 12, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Extrawell Pharmaceutical Holdings Limited |
Symbool | 0858.HK |
Munteenheid | HKD |
Prijs | 0.049 |
Beurswaarde | 117,110,000 |
Dividendpercentage | 0% |
52-weken bereik | 0.026 - 0.069 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Yi Xie Ph.D. |
Website | https://www.extrawell.com.hk |
An error occurred while fetching data.
Over Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)